Florida AG Sues Pfizer Over COVID Vaccine Claims, Seeks Fines and Disgorgement
PFE sits 19% above its 52-week low of $23.62.
Summary
Florida's Attorney General filed suit against Pfizer and its CEO, alleging misstatements about COVID-19 vaccine efficacy and safety. The complaint seeks fines, disgorgement, and injunctive relief, and cites a 2023 price increase to $110-$130 per dose. Pfizer disputes the claims. This legal action adds regulatory and reputational risk to a company already facing scrutiny over vaccine contracts and pricing. The lawsuit follows positive Phase 2 data for tilrekimig in atopic dermatitis, but the legal overhang may weigh on sentiment.
At the time of this announcement, PFE was trading at $28.12 on NYSE in the Life Sciences sector, with a market capitalization of approximately $160.3B. The 52-week trading range was $23.62 to $29.21. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.